Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan.

MLA

Sullivan, Sean D., et al. “Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine Treatment in Patients with Hepatitis B e Antigen Positive Chronic Hepatitis B in Taiwan.” Journal of Gastroenterology & Hepatology, vol. 22, no. 9, Sept. 2007, pp. 1494–99. EBSCOhost, https://doi.org/10.1111/j.1440-1746.2006.04539.x.

APA

Sullivan, S. D., Veenstra, D. L., Chen, P.-J., Chang, T.-T., Chuang, W.-L., Tsai, C., & Patel, K. (2007). Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan. Journal of Gastroenterology & Hepatology, 22(9), 1494–1499. https://doi.org/10.1111/j.1440-1746.2006.04539.x

Chicago

Sullivan, Sean D, David L Veenstra, Pei-Jer Chen, Ting-Tsung Chang, Wan-Long Chuang, Chiaming Tsai, and Kavita Patel. 2007. “Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine Treatment in Patients with Hepatitis B e Antigen Positive Chronic Hepatitis B in Taiwan.” Journal of Gastroenterology & Hepatology 22 (9): 1494–99. doi:10.1111/j.1440-1746.2006.04539.x.